REVIEW article
Front. Cardiovasc. Med.
Sec. Cardiovascular Metabolism
Emerging Roles of Spexin in Cardiovascular Homeostasis
Provisionally accepted
- Southwest Medical University Institute of Cardiovascular Research, Luzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Spexin (SPX) is a highly conserved, proteolytically processed 14-amino acid peptide hormone derived from spexin precursor, originally identified through a bioinformatics-based prediction algorithm. SPX possesses pleiotropic effects across multiple organ system and has been implicated in the regulation of appetite, lipid and glucose metabolism, reproduction, inflammation, oxidative stress, neuropsychiatric functions, and cardiovascular physiology, with emerging evidence indicating sex-dependent effects in reproduction and metabolism. SPX exerts its biological effects via galanin receptors, engaging diverse G-protein coupled receptor signaling pathways. Altered SPX expression has been observed in a range of metabolic and systemic conditions, including obesity and metabolic syndrome, type 2 diabetes, hypertension, anxiety and depression, chronic kidney disease, non-alcoholic fatty liver disease, and aging, among others, highlighting its potential as both a diagnostic biomarker and a therapeutic target. Recent research suggests that SPX contributes to cardiovascular homeostasis by modulating autonomic regulation, inflammatory response, cardiomyocyte apoptosis, vascular tone, carotid body chemoreception, lipid metabolism, and insulin sensitivity, all of which are critical for maintaining cardiovascular health. This review concisely summarizes the distribution and regulation of SPX, with a focus on its emerging roles in the pathogenesis of cardiovascular disease and its potential as a theranostic agent.
Keywords: cardiovascular disease, diabetes, metabolic syndrome, Neuropeptide, spexin
Received: 16 Sep 2025; Accepted: 07 Jan 2026.
Copyright: © 2026 Wang, Xie, Li, Mao and Dang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Xitong Dang
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.